The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation
Official Title: A Multilevel Intervention (Potlako+) to Improve Timely Cancer Detection and Treatment
Study ID: NCT04141449
Brief Summary: This study evaluates whether the Potlako+ intervention of community education, clinical provider support, and patient navigation can improve access to cancer case for patients presenting with symptoms of cancer. Half of communities will receive the Potlako+ intervention, while the other communities will continue to receive standard programs.
Detailed Description: The Potlako+ trial is a pair-matched, community-randomized study involving 20 rural and peri-urban communities in Botswana (population \~190,100 with \~100,000 30 years or older). Communities will be randomized 1:1 to the Potlako+ intervention versus standard care. The goal of the intervention is to identify individuals with symptoms/signs suggestive of cancer and expedite diagnosis (and treatment). The trial includes a community education component focused on cancer awareness and importance of early diagnosis and a patient navigation component that aims to expedite the diagnostic evaluation. Community education will be directed at approximately 50,000 community residents (30 years and older). We anticipate approximately 1500 cancer suspects will be identified by their clinic providers.
Minimum Age: 30 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Botswana Harvard AIDS Institute, Gaborone, , Botswana
Name: Scott Dryden-Peterson, MD, MSc
Affiliation: Brigham and Women's Hospital, Botswana Harvard AIDS Institute
Role: PRINCIPAL_INVESTIGATOR